Both in Pharmaceuticals
Ernexa Therapeutics vs Propanc Biopharma
Over the past year ERNA returned −93.7% and PPCB returned −99.4%; their daily moves had a correlation of 0.06.
ERNA −93.7% PPCB −99.4%Growth of $1, one year, split-adjusted
| Metric | ERNA | PPCB |
|---|---|---|
| Price | $1.98 | $2.11 |
| Market cap | $2.3M | $20.7M |
| Today | −0.66% | −13.17% |
| 1 month | −37.3% | −58.8% |
| 6 months | −57.7% | −91.6% |
| Year to date | −93.4% | −98.4% |
| 1 year | −93.3% | −99.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $832.0K |
| Dividend yield | — | — |
| Volatility (60d) | 79.9% | 731.5% |
| Short % of float | 2.1% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).